XyloCor Therapeutics Presents Phase 2 Data Highlighting Safety and Efficacy of XC001 at the European Society of Cardiology (ESC) Congress 2023
WAYNE, PA.--(BUSINESS WIRE)--Aug 25, 2023--
Source: galvnews.com
Fast, Ad-Free News Updates
Stay updated with breaking news from Al Gianchetti. Real-time updates on events, politics, business and more.